Rankings
▼
Calendar
INSM Q4 2024 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$104M
+24.8% YoY
Gross Profit
$78M
75.0% margin
Operating Income
-$230M
-220.6% margin
Net Income
-$236M
-225.5% margin
EPS (Diluted)
$-1.32
QoQ Revenue Growth
+11.8%
Cash Flow
Operating Cash Flow
-$196M
Free Cash Flow
-$203M
Stock-Based Comp.
$27M
Balance Sheet
Total Assets
$2.0B
Total Liabilities
$1.7B
Stockholders' Equity
$285M
Cash & Equivalents
$555M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$104M
$84M
+24.8%
Gross Profit
$78M
$65M
+20.0%
Operating Income
-$230M
-$178M
-29.2%
Net Income
-$236M
-$186M
-26.6%
Geographic Segments
UNITED STATES
$132M
68%
JAPAN
$52M
27%
Europe And The Rest Of The World
$11M
6%
← FY 2024
All Quarters
Q1 2025 →